Price history
¥5,000Latest+39.5%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
59.38How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
0.84How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
1.4%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥17bnShare price × number of shares. The value of the entire company.Equity ratio
75.9%The proportion of assets funded by money that does not have to be repaid.Operating margin
10.8%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
4.2%The average annual growth in sales over the past three years.What to watch next
Start-up of operations at the Tokai Oxygen filling plant, including whether increased supply capacity alleviates the bottleneck
Through the next reporting period, covering the several quarters after operations beginImpact HighLikelihood Medium
Progress in the market launch of the home healthcare support system "Pallet's-R" and respiratory rehabilitation device "LIC TRAINER", including the number of facilities adopting them and their contribution to contracts and revenue
From the start of the 2024 launch, with earnings impact over the near term to approximately the next yearImpact MediumLikelihood Medium
Integration benefits following the 2024 group reorganization, including the absorption mergers of 星医療酸器東海 and 星医療酸器関西, as reflected in costs, sales efficiency and actual expansion of distribution channels
Next earnings periodImpact MediumLikelihood Medium
Productivity improvements from DX, core business system upgrades and the shift to paperless operations, including cost savings in logistics and back-office functions
From fiscal 2026 onward, with benefits emerging in stagesImpact MediumLikelihood Low
What to watch next
Who owns itTop holders total 56.7%
Listed holders 56.7%Everyone else 43.3%
星医療酸器 Business Partners’ Shareholding Association18.50%
UH Partners 2 Co., Ltd.7.50%
HIKARI TSUSHIN,INC.6.80%
一星社株式会社6.40%
星 幸 男4.70%
星 孝 子3.50%
星 昌 成3.20%
星医療酸器従業員持株会2.20%
2 other listed holders3.90%
| Holder | Ownership (%) |
|---|---|
| 星医療酸器 Business Partners’ Shareholding Association | 18.50 |
| UH Partners 2 Co., Ltd. | 7.50 |
| HIKARI TSUSHIN,INC. | 6.80 |
| 一星社株式会社 | 6.40 |
| 星 幸 男 | 4.70 |
| 星 孝 子 | 3.50 |
| 星 昌 成 | 3.20 |
| 星医療酸器従業員持株会 | 2.20 |
| 2 other listed holders | 3.90 |
This company's documents
Filings
Timely disclosures
- 2026-08-07Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2027 (Japanese GAAP)
- 2026-06-25Articles of Incorporation 2026/06/25
- 2026-06-03Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials
- 2026-05-19(Correction) Partial Correction to the "Notice Regarding the Introduction of a Policy for Responding to Large-Scale Purchases of Our Shares, etc. (Takeover Response Policy)"
- 2026-05-11Notice Regarding the Introduction of a Policy for Responding to Large-Scale Purchases of Our Shares and Other Securities (Takeover Response Policy)
- 2026-05-11Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
- 2026-03-23Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock Compensation